{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:03:18Z","timestamp":1648684998425},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1097\/fpc.0000000000000372","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T04:40:13Z","timestamp":1559191213000},"page":"121","source":"Crossref","is-referenced-by-count":0,"title":["Necessity of a human leukocyte antigen-B*58"],"prefix":"10.1097","volume":"29","author":[{"given":"Alberto","family":"Sanchez-Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizzio","family":"Poma-Saavedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Garcia-Vilarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Vicente-Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria D.","family":"Perez-del-Caz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0000000000000359","article-title":"Utility of human leukocyte antigen-B*58: 01 genotyping and patient outcomes","volume":"29","author":"Ke","year":"2019","journal-title":"Pharmacogenet Genomics"},{"key":"R2-4-20210213","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/FPC.0000000000000334","article-title":"A retrospective investigation of HLA-B*5801 in hyperuricemia patients in A Han population of China","volume":"28","author":"Cheng","year":"2018","journal-title":"Pharmacogenet Genomics"},{"key":"R3-4-20210213","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/FPC.0000000000000358","article-title":"Allopurinol-induced TEN and association with HLA B*58: 01 in White patients","volume":"28","author":"Poma-Saavedra","year":"2018","journal-title":"Pharmacogenet Genomics"},{"key":"R4-4-20210213","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jamainternmed.2018.3556","article-title":"HLA-B*5801 testing to prevent allopurinol hypersensitivity syndrome: a teachable moment","volume":"178","author":"Quach","year":"2018","journal-title":"JAMA Intern Med"},{"key":"R5-4-20210213","first-page":"296","article-title":"Rapid, reliable, and inexpensive HLA-B*58:01 detection method using DNA binding dye-based duplex allele-specific melting curve analysis","volume":"48","author":"Huh","year":"2018","journal-title":"Ann Clin Lab Sci"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:24:42Z","timestamp":1620951882000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201907000-00004"}},"subtitle":["01 screening test for preventing severe cutaneous adverse reactions"],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000372","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}